News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
473,748 Results
Type
Article (25001)
Company Profile (159)
Press Release (448581)
Multimedia
Podcasts (46)
Webinars (14)
Section
Business (123905)
Career Advice (451)
Deals (20400)
Drug Delivery (52)
Drug Development (79414)
Employer Resources (44)
FDA (12704)
Job Trends (9323)
News (233582)
Policy (18689)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (1695)
Academic (1)
Accelerated approval (27)
Adcomms (29)
Allergies (131)
Alliances (33748)
ALS (170)
Alzheimer's disease (1630)
Antibody-drug conjugate (ADC) (301)
Approvals (13000)
Artificial intelligence (449)
Autoimmune disease (144)
Automation (27)
Bankruptcy (146)
Best Places to Work (8155)
BIOSECURE Act (12)
Biosimilars (132)
Biotechnology (119)
Bladder cancer (153)
Brain cancer (57)
Breast cancer (625)
Cancer (4629)
Cardiovascular disease (371)
Career advice (405)
Career pathing (19)
CAR-T (270)
CDC (11)
Celiac Disease (2)
Cell therapy (684)
Cervical cancer (36)
Clinical research (69362)
Collaboration (1449)
Company closure (3)
Compensation (844)
Complete response letters (43)
COVID-19 (2136)
CRISPR (71)
C-suite (693)
Cystic fibrosis (136)
Data (6070)
Decentralized trials (2)
Denatured (21)
Depression (134)
Diabetes (420)
Diagnostics (5393)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (17)
Drug discovery (198)
Drug pricing (47)
Drug shortages (12)
Duchenne muscular dystrophy (197)
Earnings (50222)
Editorial (24)
Employer branding (3)
Employer resources (43)
Events (77355)
Executive appointments (796)
FDA (15512)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (21)
Funding (1250)
Gene editing (167)
Generative AI (39)
Gene therapy (520)
GLP-1 (723)
Government (2338)
Grass and pollen (6)
Guidances (299)
Healthcare (13767)
HIV (45)
Huntington's disease (47)
IgA nephropathy (81)
Immunology and inflammation (213)
Immuno-oncology (48)
Indications (98)
Infectious disease (2340)
Inflammatory bowel disease (189)
Inflation Reduction Act (4)
Influenza (95)
Intellectual property (205)
Interviews (63)
IPO (10997)
IRA (13)
Job creations (1494)
Job search strategy (351)
JPM (29)
Kidney cancer (16)
Labor market (36)
Layoffs (326)
Leadership (16)
Legal (2299)
Liver cancer (82)
Longevity (13)
Lung cancer (625)
Lymphoma (357)
Machine learning (31)
Management (14)
Manufacturing (499)
MASH (156)
Medical device (9536)
Medtech (9578)
Mergers & acquisitions (10277)
Metabolic disorders (1013)
Multiple sclerosis (151)
NASH (14)
Neurodegenerative disease (303)
Neuropsychiatric disorders (79)
Neuroscience (2781)
Neurotech (1)
NextGen: Class of 2026 (3879)
Non-profit (2429)
Now hiring (37)
Obesity (418)
Opinion (180)
Ovarian cancer (159)
Pain (190)
Pancreatic cancer (220)
Parkinson's disease (273)
Partnered (24)
Patents (391)
Patient recruitment (488)
Peanut (52)
People (38739)
Pharmaceutical (36)
Pharmacy benefit managers (7)
Phase 1 (22343)
Phase 2 (30881)
Phase 3 (22372)
Pipeline (4684)
Policy (99)
Postmarket research (2054)
Preclinical (8054)
Press Release (28)
Prostate cancer (225)
Psychedelics (40)
Radiopharmaceuticals (271)
Rare diseases (745)
Real estate (2913)
Recruiting (17)
Regulatory (17764)
Reports (26)
Research institute (1884)
Resumes & cover letters (60)
Rett syndrome (27)
RNA editing (13)
RSV (48)
Schizophrenia (134)
Series A (222)
Series B (179)
Service/supplier (8)
Sickle cell disease (80)
Special edition (14)
Spinal muscular atrophy (151)
Sponsored (27)
Startups (2410)
State (1)
Stomach cancer (15)
Supply chain (51)
Tariffs (15)
The Weekly (25)
Vaccines (690)
Venture capital (55)
Weight loss (233)
Women's health (74)
Worklife (6)
Date
Today (20)
Last 7 days (503)
Last 30 days (1642)
Last 365 days (25461)
2026 (2400)
2025 (25740)
2024 (29266)
2023 (33132)
2022 (41019)
2021 (42973)
2020 (39530)
2019 (30527)
2018 (22971)
2017 (23778)
2016 (21705)
2015 (25405)
2014 (18364)
2013 (13799)
2012 (14427)
2011 (14803)
2010 (13940)
Location
Africa (373)
Alabama (73)
Alaska (3)
Arizona (172)
Arkansas (8)
Asia (28978)
Australia (5640)
California (9765)
Canada (2489)
China (1010)
Colorado (391)
Connecticut (400)
Delaware (276)
Europe (66248)
Florida (1346)
Georgia (305)
Hawaii (2)
Idaho (41)
Illinois (574)
India (41)
Indiana (402)
Iowa (17)
Japan (374)
Kansas (98)
Kentucky (33)
Louisiana (18)
Maine (27)
Maryland (1043)
Massachusetts (6946)
Michigan (198)
Minnesota (410)
Mississippi (4)
Missouri (92)
Montana (30)
Nebraska (17)
Nevada (102)
New Hampshire (64)
New Jersey (2458)
New Mexico (23)
New York (2565)
North Carolina (1205)
North Dakota (6)
Northern California (4803)
Ohio (253)
Oklahoma (20)
Oregon (36)
Pennsylvania (1886)
Puerto Rico (14)
Rhode Island (24)
South America (488)
South Carolina (43)
Southern California (3853)
Tennessee (132)
Texas (1572)
United States (33285)
Utah (262)
Vermont (1)
Virginia (214)
Washington D.C. (54)
Washington State (777)
West Virginia (2)
Wisconsin (80)
Wyoming (1)
473,748 Results for "oncobay clinical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Hillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216
Hillstream BioPharma, Inc. has selected immune-oncology clinical research organization (CRO), OncoBay Clinical , to provide comprehensive clinical and regulatory support for the clinical development program for its lead drug candidate HSB-1216.
April 13, 2023
·
4 min read
Press Releases
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
January 8, 2026
·
2 min read
Press Releases
TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg Therapeutics
January 27, 2026
·
4 min read
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
AstraZeneca’s $15 billion pledge to its China operations highlights the country’s advantages. But other regions are also hoping to host more clinical studies.
February 2, 2026
·
8 min read
·
Annalee Armstrong
Press Releases
Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities
January 20, 2026
·
3 min read
Business
Clinscience joins forces with Florida-based oncological CRO, OncoBay Clinical
Neuca Clinical Trials Inc, a holding company held by Neuca Group, the proprietor of Clinscience international CRO, reiterates its commitment to advancing clinical research through Technology and Data Integrity by increasing its clinical operations in the US.
January 4, 2023
·
2 min read
Press Releases
Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved
December 23, 2025
·
7 min read
Press Releases
Theralase(R) Provides Update on Bladder Cancer Clinical Study
Interim clinical data has exceeded the recommended guidelines of the International Bladder Cancer Group for complete response and duration of complete response
February 4, 2026
·
7 min read
Business
OncoBay Clinical Announces Technology Partnership with Protocol First
OncoBay Clinical Inc., a full-service boutique contract research organization (CRO) specializing in the simplification of complex oncology programs, today announced a strategic partnership with Protocol First, Inc., a software solutions provider focused on accelerating clinical research.
May 11, 2021
·
3 min read
Clinical research
5 Clinical Readouts to Watch in H1 2026
As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate pelacarsen to a Phase III test of Eli Lilly’s next-gen Alzheimer’s drug—are poised to reshape therapeutic landscapes.
January 5, 2026
·
7 min read
·
Ben Hargreaves
1 of 47,375
Next
